Bone mineral density and parathyroid function in patients on maintenance hemodialysis

C. Ambrus, Cs Almasi, K. Berta, Gy Deak, A. Marton, M. Molnár, Zs Nemeth, C. Horváth, P. Lakatos, M. Szathmári, I. Mucsi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: The relationship between parathyroid function, an important determinant of bone turnover, and bone mineral density (BMD) in patients with chronic kidney disease is not fully understood. We wanted to analyze the association between BMD and parathyroid function in hemodialysis patients in details. Methods: In a cross-sectional design, data from 270 patients (age 55 ± 15 years, 60% men, all Caucasian) on maintenance hemodialysis were analyzed. All patients underwent dual energy X-ray absorptiometry of the lumbar spine (LS), femoral neck (FN) and distal radius (DR). In addition to routine laboratory tests, blood samples were collected for iPTH, serum markers of bone metabolism (alkaline phosphatase, type I collagen crosslinked-C-telopeptide) and 25OH vitamin D. Results: Based on Z-scores, bone mineral density was moderately reduced only at the femoral neck in the total cohort. The average Z-score of the "low PTH" group (iPTH <100 pg/ml) was not different from the Z-score of patients with iPTH in the "target range" (100-300 pg/ml) at any measurement site. While iPTH was negatively correlated with BMD at all measurement sites in patients with iPTH > 100 pg/ml (rho = -0.255, -0.278 and -0.251 for LS, FN and DR, respectively, P <0.001 for all), BMD was independent of iPTH in patients with iPTH <100 pg/ml. Furthermore, iPTH was not associated with serum markers of bone metabolism, but these markers were negatively correlated with BMD in the "low PTH" group. Conclusions: Low PTH levels are not associated with low BMD in patients with end-stage kidney disease. Furthermore, bone metabolism seems to be independent of iPTH in patients with relative hypoparathyroidism likely reflecting skeletal resistance to PTH.

Original languageEnglish
Pages (from-to)191-201
Number of pages11
JournalInternational Urology and Nephrology
Volume43
Issue number1
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Bone Density
Renal Dialysis
Maintenance
Femur Neck
Bone and Bones
Spine
Biomarkers
Hypoparathyroidism
Bone Remodeling
Photon Absorptiometry
Hematologic Tests
Collagen Type I
Chronic Renal Insufficiency
Vitamin D
Chronic Kidney Failure
Alkaline Phosphatase

Keywords

  • Bone mineral density
  • Bone turnover markers
  • Hemodialysis
  • Metabolic bone diseases
  • Renal osteodystrophy

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Bone mineral density and parathyroid function in patients on maintenance hemodialysis. / Ambrus, C.; Almasi, Cs; Berta, K.; Deak, Gy; Marton, A.; Molnár, M.; Nemeth, Zs; Horváth, C.; Lakatos, P.; Szathmári, M.; Mucsi, I.

In: International Urology and Nephrology, Vol. 43, No. 1, 03.2011, p. 191-201.

Research output: Contribution to journalArticle

@article{04aa47f10601426a8a4961b1f975384e,
title = "Bone mineral density and parathyroid function in patients on maintenance hemodialysis",
abstract = "Background: The relationship between parathyroid function, an important determinant of bone turnover, and bone mineral density (BMD) in patients with chronic kidney disease is not fully understood. We wanted to analyze the association between BMD and parathyroid function in hemodialysis patients in details. Methods: In a cross-sectional design, data from 270 patients (age 55 ± 15 years, 60{\%} men, all Caucasian) on maintenance hemodialysis were analyzed. All patients underwent dual energy X-ray absorptiometry of the lumbar spine (LS), femoral neck (FN) and distal radius (DR). In addition to routine laboratory tests, blood samples were collected for iPTH, serum markers of bone metabolism (alkaline phosphatase, type I collagen crosslinked-C-telopeptide) and 25OH vitamin D. Results: Based on Z-scores, bone mineral density was moderately reduced only at the femoral neck in the total cohort. The average Z-score of the {"}low PTH{"} group (iPTH <100 pg/ml) was not different from the Z-score of patients with iPTH in the {"}target range{"} (100-300 pg/ml) at any measurement site. While iPTH was negatively correlated with BMD at all measurement sites in patients with iPTH > 100 pg/ml (rho = -0.255, -0.278 and -0.251 for LS, FN and DR, respectively, P <0.001 for all), BMD was independent of iPTH in patients with iPTH <100 pg/ml. Furthermore, iPTH was not associated with serum markers of bone metabolism, but these markers were negatively correlated with BMD in the {"}low PTH{"} group. Conclusions: Low PTH levels are not associated with low BMD in patients with end-stage kidney disease. Furthermore, bone metabolism seems to be independent of iPTH in patients with relative hypoparathyroidism likely reflecting skeletal resistance to PTH.",
keywords = "Bone mineral density, Bone turnover markers, Hemodialysis, Metabolic bone diseases, Renal osteodystrophy",
author = "C. Ambrus and Cs Almasi and K. Berta and Gy Deak and A. Marton and M. Moln{\'a}r and Zs Nemeth and C. Horv{\'a}th and P. Lakatos and M. Szathm{\'a}ri and I. Mucsi",
year = "2011",
month = "3",
doi = "10.1007/s11255-009-9702-2",
language = "English",
volume = "43",
pages = "191--201",
journal = "International Urology and Nephrology",
issn = "0301-1623",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Bone mineral density and parathyroid function in patients on maintenance hemodialysis

AU - Ambrus, C.

AU - Almasi, Cs

AU - Berta, K.

AU - Deak, Gy

AU - Marton, A.

AU - Molnár, M.

AU - Nemeth, Zs

AU - Horváth, C.

AU - Lakatos, P.

AU - Szathmári, M.

AU - Mucsi, I.

PY - 2011/3

Y1 - 2011/3

N2 - Background: The relationship between parathyroid function, an important determinant of bone turnover, and bone mineral density (BMD) in patients with chronic kidney disease is not fully understood. We wanted to analyze the association between BMD and parathyroid function in hemodialysis patients in details. Methods: In a cross-sectional design, data from 270 patients (age 55 ± 15 years, 60% men, all Caucasian) on maintenance hemodialysis were analyzed. All patients underwent dual energy X-ray absorptiometry of the lumbar spine (LS), femoral neck (FN) and distal radius (DR). In addition to routine laboratory tests, blood samples were collected for iPTH, serum markers of bone metabolism (alkaline phosphatase, type I collagen crosslinked-C-telopeptide) and 25OH vitamin D. Results: Based on Z-scores, bone mineral density was moderately reduced only at the femoral neck in the total cohort. The average Z-score of the "low PTH" group (iPTH <100 pg/ml) was not different from the Z-score of patients with iPTH in the "target range" (100-300 pg/ml) at any measurement site. While iPTH was negatively correlated with BMD at all measurement sites in patients with iPTH > 100 pg/ml (rho = -0.255, -0.278 and -0.251 for LS, FN and DR, respectively, P <0.001 for all), BMD was independent of iPTH in patients with iPTH <100 pg/ml. Furthermore, iPTH was not associated with serum markers of bone metabolism, but these markers were negatively correlated with BMD in the "low PTH" group. Conclusions: Low PTH levels are not associated with low BMD in patients with end-stage kidney disease. Furthermore, bone metabolism seems to be independent of iPTH in patients with relative hypoparathyroidism likely reflecting skeletal resistance to PTH.

AB - Background: The relationship between parathyroid function, an important determinant of bone turnover, and bone mineral density (BMD) in patients with chronic kidney disease is not fully understood. We wanted to analyze the association between BMD and parathyroid function in hemodialysis patients in details. Methods: In a cross-sectional design, data from 270 patients (age 55 ± 15 years, 60% men, all Caucasian) on maintenance hemodialysis were analyzed. All patients underwent dual energy X-ray absorptiometry of the lumbar spine (LS), femoral neck (FN) and distal radius (DR). In addition to routine laboratory tests, blood samples were collected for iPTH, serum markers of bone metabolism (alkaline phosphatase, type I collagen crosslinked-C-telopeptide) and 25OH vitamin D. Results: Based on Z-scores, bone mineral density was moderately reduced only at the femoral neck in the total cohort. The average Z-score of the "low PTH" group (iPTH <100 pg/ml) was not different from the Z-score of patients with iPTH in the "target range" (100-300 pg/ml) at any measurement site. While iPTH was negatively correlated with BMD at all measurement sites in patients with iPTH > 100 pg/ml (rho = -0.255, -0.278 and -0.251 for LS, FN and DR, respectively, P <0.001 for all), BMD was independent of iPTH in patients with iPTH <100 pg/ml. Furthermore, iPTH was not associated with serum markers of bone metabolism, but these markers were negatively correlated with BMD in the "low PTH" group. Conclusions: Low PTH levels are not associated with low BMD in patients with end-stage kidney disease. Furthermore, bone metabolism seems to be independent of iPTH in patients with relative hypoparathyroidism likely reflecting skeletal resistance to PTH.

KW - Bone mineral density

KW - Bone turnover markers

KW - Hemodialysis

KW - Metabolic bone diseases

KW - Renal osteodystrophy

UR - http://www.scopus.com/inward/record.url?scp=79953816996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953816996&partnerID=8YFLogxK

U2 - 10.1007/s11255-009-9702-2

DO - 10.1007/s11255-009-9702-2

M3 - Article

C2 - 20091221

AN - SCOPUS:79953816996

VL - 43

SP - 191

EP - 201

JO - International Urology and Nephrology

JF - International Urology and Nephrology

SN - 0301-1623

IS - 1

ER -